News & Updates
Filter by Specialty:

PANTHER 10-year data support tailored dose-dense adjuvant chemo for high-risk early breast cancer
Long-term data from the phase III PANTHER trial demonstrate improved breast cancer recurrence-free survival (BCRFS) with tailored dose-dense adjuvant chemotherapy as opposed to standard adjuvant chemo in individuals with high-risk early breast cancer.
PANTHER 10-year data support tailored dose-dense adjuvant chemo for high-risk early breast cancer
18 Jun 2024
Are fertility treatments safe in young breast cancer survivors who have high-risk genes?
In young breast cancer survivors harbouring BRCA1/2 pathogenic variants, using assisted reproductive techniques (ART) to conceive did not appear to negatively affect maternal or pregnancy outcomes, findings from an international retrospective cohort study suggest.
Are fertility treatments safe in young breast cancer survivors who have high-risk genes?
13 Jun 2024
Chemo plus immunotherapy improves survival in advanced endometrial cancer
Adding immunotherapy to the first-line treatment for advanced and metastatic endometrial cancer may significantly improve some oncologic outcomes, particularly within the mismatch repair deficiency/microsatellite instability-hypermutated (MMRd/MSI-H) subset, suggests a study.
Chemo plus immunotherapy improves survival in advanced endometrial cancer
09 Jun 2024
Multiethnic GDM study points to unique gut microbiome profile
Women with gestational diabetes mellitus (GDM) share a common gut bacterial profile regardless of ethnic differences, according to a Singapore study, suggesting a role for specific gut bacteria in GDM pathophysiology.